Strategic Implications of Oncology Clinical Trial Design in Early-Phase Studies

Healthcare > Clinical Trials2/16/2024 4:00 PM

Go to Registration Page


Discover an informative webinar delving into how strategic oncology clinical trial design shapes success in early oncology studies using novel approaches. Trial design in early-phase oncology studies has a critical impact on the success of the study. Novel approaches such as biomarker stratification, adaptive enrichment designs, outcome-adaptive randomization and the integration of real-world data have been developed. In addition, under Project Optimus, dose expansion requires the selection of the most appropriate dose and schedule to be brought into the registrational trial, which also needs to be accomplished via dose-finding studies in early-phase trials. Attendees will learn insights into the trade-offs between protocol design options and offer insight into developing a trial structure that maximizes the chances of success in later phases of research while minimizing risk. Join this webinar to explore the intricate world of oncology trial design and gain valuable insights to enhance research approaches.


Rate This Webinar

community rating (0 votes): 
Rate or Review This Webinar




Caidya is a global, full-service Clinical Research Organization (CRO) that activates the full potential of your science through personalized partnerships, global expertise, and knowledge sharing. With a focus on trial transparency and a commitment to exceptional personalized experiences, Caidya offers a range of clinical research services and therapeutic area expertise. Our team is dedicated to revolutionizing the clinical research process, fostering a collaborative and performance-oriented culture, and delivering better healthcare outcomes for all.